These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29909377)

  • 1. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
    Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.
    Okada S; Morimoto T; Ogawa H; Soejima H; Matsumoto C; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y
    J Gen Intern Med; 2021 Mar; 36(3):632-639. PubMed ID: 33063203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
    Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Jinnouchi H; Waki M; Akai Y; Ishii H; Saito Y;
    PLoS One; 2016; 11(1):e0147635. PubMed ID: 26808136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
    Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
    Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
    Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
    Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
    Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
    Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
    Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
    Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
    Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer.
    Ye S; Lee M; Lee D; Ha EH; Chun EM
    JAMA Netw Open; 2019 Mar; 2(3):e190185. PubMed ID: 30821825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
    Soejima H; Ogawa H; Morimoto T; Okada S; Matsumoto C; Nakayama M; Masuda I; Jinnouchi H; Waki M; Saito Y;
    J Cardiol; 2020 Apr; 75(4):387-393. PubMed ID: 31564388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
    Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
    Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T
    BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35361621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
    Ong G; Davis TM; Davis WA
    Diabetes Care; 2010 Feb; 33(2):317-21. PubMed ID: 19918016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
    Cook NR; Lee IM; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):47-55. PubMed ID: 15998890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.